Panbela Therapeutics Probability of Future Stock Price Finishing Over 2.06
| PBLADelisted Stock | USD 2.06 0.11 5.07% |
Panbela |
Panbela Therapeutics Target Price Odds to finish over 2.06
The tendency of Panbela Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.06 | 90 days | 2.06 | about 86.63 |
Based on a normal probability distribution, the odds of Panbela Therapeutics to move above the current price in 90 days from now is about 86.63 (This Panbela Therapeutics probability density function shows the probability of Panbela Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.89 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Panbela Therapeutics will likely underperform. Additionally Panbela Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Panbela Therapeutics Price Density |
| Price |
Predictive Modules for Panbela Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Panbela Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Panbela Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Panbela Therapeutics is not an exception. The market had few large corrections towards the Panbela Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Panbela Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Panbela Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -2.51 | |
β | Beta against Dow Jones | 1.89 | |
σ | Overall volatility | 5.04 | |
Ir | Information ratio | -0.21 |
Panbela Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Panbela Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Panbela Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Panbela Therapeutics is not yet fully synchronised with the market data | |
| Panbela Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Panbela Therapeutics currently holds 6.84 M in liabilities. Panbela Therapeutics has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Panbela Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (34.93 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Panbela Therapeutics currently holds about 2.53 M in cash with (15.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. |
Panbela Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Panbela Stock often depends not only on the future outlook of the current and potential Panbela Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Panbela Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 27.8 K | |
| Cash And Short Term Investments | 1.3 M |
Panbela Therapeutics Technical Analysis
Panbela Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Panbela Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Panbela Therapeutics. In general, you should focus on analyzing Panbela Stock price patterns and their correlations with different microeconomic environments and drivers.
Panbela Therapeutics Predictive Forecast Models
Panbela Therapeutics' time-series forecasting models is one of many Panbela Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Panbela Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Panbela Therapeutics
Checking the ongoing alerts about Panbela Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Panbela Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Panbela Therapeutics is not yet fully synchronised with the market data | |
| Panbela Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Panbela Therapeutics currently holds 6.84 M in liabilities. Panbela Therapeutics has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Panbela Therapeutics' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (34.93 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Panbela Therapeutics currently holds about 2.53 M in cash with (15.28 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Panbela Stock
If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |